ICICI Direct recommended hold rating on Ipca Laboratories with a target price of Rs 560 in its research report dated February 13, 2017.
Edelweiss is bearish on Ipca Labs has recommended reduce rating on the stock with a target price of Rs 440 in its research report dated April 7, 2016.
Motilal Oswal has recommended neutral rating on Ipca Labs with a target price of Rs 680 in its research report dated February 8, 2016.
Reliance Securities, has recommend Hexaware, Persistent, HDFC Bank, IPCA Lab and Shriram Transport as Top Stocks Picks for Diwali Samvat 2072
Edelweiss has recommended a reduce rating on Ipca Laboratories with a target price of Rs 565, in its November 04, 2015 research report.
Sharekhan has recommended hold rating on Ipca Laboratories with a target price of Rs 779 in its research report dated November 4, 2015.
Emkay Global Financial Services has recommended hold rating on Ipca Laboratories with a target price of Rs 700, in its research report dated August 3, 2015.
Angel Broking is bullish on Ipca Laboratories and has recommended buy rating on the stock with a target of Rs 736 in its research report dated June 9, 2015.
Sharekhan has recommended to hold Ipca Laboratories, in its research report dated March 25, 2015.
ICICIdirect.com has recommended to hold Ipca Laboratories with a target price of Rs 622, in its research report dated March 25, 2015.
Angel Broking is bullish on Ipca Laboratories and has recommended buy rating on the stock with a target of Rs 759 in its February 11, 2015 research report.
Religare believes that, the equity market‘s momentum is likely to continue during next year also. Investors can use the volatility to pick strong fundamental stocks for long term, says the report.
Angel Broking is bullish on Ipca Laboratories and has recommended buy rating on the stock with a target of Rs 817 in its November 14, 2014 research report.
Brokerage house Motilal Oswal is bullish on Ipca Laboratories and has recommended buy rating on the stock with a target price of Rs 809, in its research report dated November 11, 2014.
Dolat Capital has come out with its report on preferred buy list. The research firm has recommended to buy 13 stocks in its research report dated August 25, 2014.
Angel Broking is bullish on Ipca Labs and has recommended buy rating on the stock with a target of Rs 986 in its August 04, 2014 research report.
Brokerage house Angel Broking is bullish on Ipca Laboratories and has recommended 'Accumulate' rating on the stock with a target price of Rs 882 in its research report dated June 02, 2014.
Sushil Finance has recommended hold rating on Ipca Laboratories with a target price of Rs 748, in its October 11, 2013 research report.
Hem Securities is bullish on Ipca Laboratories and has recommended buy rating on the stock with a target price of Rs 780 in its August 26, 2013 research report.
Brokerage house Firstcall Research is bullish on Ipca Laboratories and has recommended buy rating on the stock with a target price of Rs 706 in its August 21, 2013 research report.
Firstcall Research is bullish on IPCA Laboratories and has recommended buy rating on the stock with a target price of Rs 581 in its March 18, 2013 research report.
Dolat Capital is bullish on Ipca Laboratories and has recommended accumulate rating on the stock with a target price of Rs 572 in its March 11, 2013 research report.
Motilal Oswal is bullish on Ipca Laboratories and has recommended buy rating on the stock with a target of Rs 645 in its February 1, 2013 research report.
Dolat Capital is bullish on Ipca Laboratories and has recommended accumulate rating on the stock with a target of Rs 572 in its January 31, 2013 research report.
Angel Broking is bullish on Ipca Laboratories and has recommended buy rating on the stock with a target of Rs 559 in its January 30, 2013 research report.